TIOPRONIN

Generic: TIOPRONIN

Par Health USAManufacturer
ORALRoute
TIOPRONINActive Substance
2023-02-24Original Approval

TIOPRONIN is FDA application ANDA217219, sponsored by PH HEALTH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
OFF LABEL USE
19 reports
2
NEPHROTIC SYNDROME
14 reports
3
PYREXIA
14 reports
4
NAUSEA
13 reports
5
DIARRHOEA
12 reports
6
TUBULOINTERSTITIAL NEPHRITIS
12 reports
7
VOMITING
12 reports
8
PNEUMONIA
11 reports
9
ALANINE AMINOTRANSFERASE INCREASED
9 reports
10
ASPARTATE AMINOTRANSFERASE INCREASED
9 reports